SYLVANT
Google image searchProduct monograph
Active ingredient
siltuximab, 100 MG/VIAL
DIN: 02435128
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE USE VIAL
Schedule: Prescription
Company: EUSA PHARMA (UK) LIMITED
Date: 12-AUG-2021
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AC — Interleukin inhibitors (ATC, ATC/DDD)
- L04AC11 — SILTUXIMAB (ATC/DDD)
